As of November 2024 Outlook Therapeutics has 250.18M shares outstanding, a increase of 17.96% from 2023. It represents the total number of shares of a company that are owned by all its shareholders, including both public investors and company insiders.
Year | Shares outstanding | Change |
---|---|---|
2023 | 250.18M | 17.96% |
2022 | 212.08M | 38.91% |
2021 | 152.68M | 110.43% |
2020 | 72.56M | - |